<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001876'>Pancytopenia</z:hpo> with severe bone marrow <z:mpath ids='MPATH_589'>dysplasia</z:mpath> following allogeneic bone marrow transplantation for <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (M6) may pose a diagnostic problem </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of M6 <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> in which progressive <z:mp ids='MP_0000248'>macrocytosis</z:mp>, <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and severe bone marrow <z:mpath ids='MPATH_589'>dysplasia</z:mpath> induced by <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> therapy developed after successful engraftment of a donor marrow </plain></SENT>
<SENT sid="2" pm="."><plain>We discuss the diagnostic problems and the usefulness of conventional cytogenetics and interphase fluorescence in situ hybridisation in excluding recipient <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> relapse </plain></SENT>
<SENT sid="3" pm="."><plain>We also suggest that <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> should be used with caution, especially following bone marrow transplantation </plain></SENT>
</text></document>